Windlas Biotech IPO Listing
Last Updated: 12th December 2022 - 02:00 pm
Windlas Biotech had a discouraging listing on 16 August as it listed at a discount to the issue price and during the day the discount only widened. The sharp fall in the GMP was already indicative of a weak listing, but the actual listing was below what the GMP had indicated. Windlas Biotech listed at a discount of -5% and traded through the day below the issue price of Rs.460. In fact, even the high price of the day was well below the issue price. With overall subscription of over 22.44X, listing response was fairly discouraging. Here is the Windlas Biotech listing story on 16 August.
The Windlas Biotech IPO price was fixed at the upper end of the band at Rs.460 after the 22.44X subscription. On 16 Aug, the stock of Windlas Biotech listed on the NSE at a price of Rs.437, a discount of -5% on the issue price. On the BSE, the stock listed at a price of Rs.439, a listing discount of -4.6%.
On the NSE, Windlas Biotech closed at Rs.406, a first day closing discount of -11.74% on the issue price. On the BSE, the stock closed at Rs.406.70, a first day closing discount of -11.6% on the issue price.
On Day-1 of listing, Windlas Biotech touched a high of Rs.452 on the NSE and a low of Rs.405. On Day-1, the Windlas Biotech stock traded a total of 41.04 lakh shares on NSE amounting to value of Rs.174.35 crore. The stock closed near to the low of the day.
On the BSE, Windlas Biotech touched a high of Rs.452.10 and a low of Rs.405. On BSE, the stock traded a total of 3.27 lakh shares amounting to value of Rs.13.89 crore. At the close of Day-1, Windlas Biotech had a market capitalization of Rs.886 crore with free-float market cap of just Rs.248 crore.
Check:
Trending on 5paisa
5paisa Research Team
Tanushree JaiswalDiscover more of what matters to you.
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.
Want to Use 5paisa
Trading App?
